© Copyright - Neuro-Sys 2023-2024
© Copyright - Neuro-Sys 2022-2024
© Copyright - Neuro-Sys 2022-2024
© Copyright - Neuro-Sys 2023-2024
Your R&D
department
%20Glass%20Trophy%20.png)
Experts in
neurodegenerative
preclinical modelling
services
40%
of PhDs
220+ studies
in 2023
80%
of bespoke models
10700 sq ft
of labs
70+
posters & publications
Latest
news
AWARDS December, 2024
🌟Neuro-Sys Honored with "Best Neurodegenerative Disease CRO 2024" Award! by Global Health Pharma🌟
We are proud to announce that Neuro-Sys has been awarded the prestigious title of "Best Neurodegenerative Disease CRO 2024"! 🏆
This recognition is the result of the hard work and dedication of our talented team, who strive every day to deliver the highest quality studies in neurodegenerative disease research.
We would like to extend our heartfelt gratitude to each of our team members for their expertise, passion, and commitment. A special thanks to our clients for their trust and collaboration. It's because of you that we can continue to push the boundaries of research.
This award is not just an achievement; it is a springboard for new challenges and opportunities. We look forward to continuing our mission and reaching new heights together!
EVENT September, 2024: 🚀 Neuro-Sys Takes Flight: Unveiling Our Cutting-Edge Research Hub!
We are thrilled to announce a transformative milestone in Neuro-Sys' journey! We've moved into our new state-of-the-art facility, spanning an impressive 2,000 m² (approx. 20,000 sq ft). This expansion marks a quantum leap in our capabilities to drive innovation in neurodegenerative research.
Key highlights of our expansion:
-
4x larger space, enabling simultaneous complex studies
-
A talented, specialized team of 40+ experts
-
Massive investment in cutting-edge equipment
-
Enhanced capacity for more robust and relevant studies
This move empowers us to deliver even more powerful, pertinent, and reliable studies to our valued clients in the pharmaceutical, biotech, and academic sectors.
We're excited to push the boundaries of neurodegenerative research further than ever before. Stay tuned for more updates as we embark on this thrilling new chapter!
EVENT Winner of Neuro-Sys' Ball Game, AAIC 24, Philadelphia
Congratulations to Sasha Milton from University of California, San Francisco, who scored Phillies vs. Yankees tickets as part of NEURO-SYS’ AAIC24 giveaway! We hope that he'll enjoy the game and have an unforgettable experience at Citizens Bank Park.
Special thanks to everyone who participated and helped make our giveaway a success.
EVENT June 3-6, 2024, San Diego, CA
Neuro-Sys will attend the Bio International Convention.
Our CEO, CSO and VP of Business Development invite you to the partnering meetings and explore collaborative opportunities with Neuro-Sys!
> More
EVENT May 21-23, 2024, Boston, MA
Neuro-Sys will sponsor and exhibit at the 3rd Annual ALS Drug Development Summit
> More
EVENT April 23-25, 2024, Boston, MA
Neuro-Sys will sponsor and exhibit at the 12th Annual Alzheimer's & Parkinson's Drug Development Summit
Our CSO will be giving a talk on: "Parkinson’s disease: alpha-synuclein’s mechanisms of cell death in vitro and in vivo evidences"
> More
INNOVATION January 18, 2024
CORTEX AI project
Thanks to the innovative integration of artificial intelligence into Neuro-Sys processes, CORTEX AI promises to revolutionize neuroscientific studies with unmatched precision, efficiency, and speed. This advanced technology enables complex data analysis for a better understanding of the mechanisms of action in neurodegenerative diseases, offering new perspectives and solutions in this critical field.
> More
POSTERS November 15, 2023
Poster presentation @SFN 2023
"Toxicity of amyloid beta oligomers involves chronic hyperphosphorylation of Tau: evidence from in vitro and in vivo models."
Poster # N6P45
POSTERS November 14, 2023
Poster presentation @SFN 2023
"SOD1G93A mutation connects mitochondrial dysfunctions, neuromuscular junction disruption and increased sensitivity to glutamatergic stress in in vitro models of ALS."
Poster # N6P44
AWARDS October, 2023
We are proud to announce that Neuro-Sys has been awarded
"Best CRO of the Year 2023" for Europe by Global Health & Pharma (UK).
This is a tribute to the quality work of our teams and the excellence of our scientific integrity that we offer to our clients and partners every day.
> More
EVENT October 9-10, 2023, London, UK
Neuro-Sys will sponsor and exhibit at the 6th Annual Neuroscience R&D Conference
Our CSO will be giving a talk on:
"Parkinson’s disease: alpha-synuclein toxicity and spreading, in vitro and in vivo models."
PUBLICATIONS August 09, 2022
NX210c Peptide Promotes Glutamatergic Receptor-Mediated Synaptic Transmission and Signaling in the Mouse Central Nervous System
Sighild Lemarchant, Mélissa Sourioux, Juliette Le Douce, Alexandre Henriques, Noelle Callizot, Sandrine Hugues, Mélissa Farinelli and Yann Godfrin
> More
POSTERS August 01, 2022
Poster presentation @AAIC 2022
"Neuroinflammation and microglial activation in Alzheimer’s Disease: in vitro and in vivo models of study."
Poster # N6P42
POSTERS July 13, 2022
Poster presentation @FENS 2022
"New in vivo model of Parkinson’s disease involving combined toxicity of alpha-synuclein oligomers and protofibrils, and chronic inhibition of GBA."
Poster # N6P41
POSTERS July 12, 2022
Poster presentation @FENS 2022
"Loss of GBA activity exacerbate the toxicity of alpha-synuclein oligomers and protofibrils in an in vitro model of Parkinson’s disease."
Poster # N6P40
AWARDS August 29, 2021
Neuro-Sys inc. elected 2021 World's Best CRO of the year by Corporate Live Wire (UK).
We are very proud of this distinction, which congratulates several years of preclinical scientific excellence, the continuous efforts of our team of experts and the significant investments undertaken.
PUBLICATIONS August 30, 2021
NSP01, a green extract of Huperzia serrata with neuroprotective effects related to synergistic action of Huperzine A and polyphenols
Noelle Callizot, Maria-Letizia Campanari, Laura Rouvière, Guillaume Jacquemot, Alexandre Henriques, Elnur Garayev and Philippe Poindron
> More
PUBLICATIONS August 19, 2021
AZP2006, a new promising treatment for Alzheimer’s and related diseases
N Callizot, C Estrella, S Burlet, A Henriques, C Brantis, M Barrier, M L Campanari, P Verwaerde
> More
PLATFORMS March 8, 2021
The histology department is strengthened with the reinforcement of the team and the investment in the latest equipment.
> More
